Trade Summary

3 days ago, Jones Jeffrey Alan, serving as Chief Medical Officer at Cullinan Therapeutics, Inc. (CGEM), sold 4,582 shares at $14.47 per share, for a total transaction value of $66,302.00. Following this transaction, Jones Jeffrey Alan now holds 159,968 shares of CGEM.

This sale represents a 3.00% decrease in Jones Jeffrey Alan's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, February 24, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 25, 2026, 1 day after the trade was made.

Cullinan Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.